Convergence Investment Partners LLC bought a new position in Genpact Limited (NYSE:G - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,019 shares of the business services provider's stock, valued at approximately $731,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Creative Planning raised its holdings in shares of Genpact by 19.4% during the third quarter. Creative Planning now owns 30,590 shares of the business services provider's stock valued at $1,199,000 after acquiring an additional 4,976 shares during the period. Sequoia Financial Advisors LLC raised its holdings in shares of Genpact by 5.8% during the third quarter. Sequoia Financial Advisors LLC now owns 23,315 shares of the business services provider's stock valued at $914,000 after acquiring an additional 1,281 shares during the period. Signaturefd LLC raised its holdings in shares of Genpact by 10.4% during the third quarter. Signaturefd LLC now owns 17,069 shares of the business services provider's stock valued at $669,000 after acquiring an additional 1,611 shares during the period. Lecap Asset Management Ltd. raised its holdings in shares of Genpact by 2.1% during the third quarter. Lecap Asset Management Ltd. now owns 18,059 shares of the business services provider's stock valued at $708,000 after acquiring an additional 364 shares during the period. Finally, Greenleaf Trust acquired a new stake in shares of Genpact during the third quarter valued at approximately $210,000. 96.03% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the stock. Mizuho boosted their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Robert W. Baird boosted their price objective on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC boosted their price objective on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $48.44.
View Our Latest Report on Genpact
Genpact Trading Down 2.1 %
NYSE G traded down $1.15 on Friday, reaching $53.33. The company had a trading volume of 722,662 shares, compared to its average volume of 1,490,206. The stock's 50 day moving average is $46.83 and its 200-day moving average is $42.59. The stock has a market cap of $9.40 billion, a price-to-earnings ratio of 18.76, a PEG ratio of 1.85 and a beta of 1.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76.
Genpact (NYSE:G - Get Free Report) last posted its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. Equities analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. The ex-dividend date is Tuesday, March 11th. This is a positive change from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.28%. Genpact's dividend payout ratio is presently 21.48%.
Insider Buying and Selling
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at $11,926,218.40. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,600 shares of company stock valued at $1,538,120. Company insiders own 2.80% of the company's stock.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report